Parc Tauli Hospital Universitari
Parc Tauli Hospital Universitari is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A phase II prospective, open-label, multi-centre, single arm study of sasanlimab plus sacituzumab govitecan in BCG (Bacillus Calmette-Guérin)- unresponsive non-muscle invasive bladder cancer (NMIBC) patients.
Sponsor Associacio Per A La Recerca Oncologica
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of the safety, tolerability, and effectiveness of CTH120 in adult males with Fragile X syndrome
Sponsor Connecta Therapeutics S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Parc Tauli Hospital Universitari?
The 2026-10-09 snapshot links Parc Tauli Hospital Universitari to 2 distinct CTIS trials. Recorded services include Laboratory services, Actigraph analyses, Plasma and urine ctDNA analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Parc Tauli Hospital Universitari?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Parc Tauli Hospital Universitari conducted?
The linked trials record locations in 1 country, including Spain. These are trial locations, not confirmed office locations or countries where Parc Tauli Hospital Universitari delivered services.
What can this page tell me about Parc Tauli Hospital Universitari's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Parc Tauli Hospital Universitari. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Parc Tauli Hospital Universitari